ArticleNephro-urology monthly2015
Translation and psychometric properties of the persian version of the dialysis symptom index in hemodialysis patients.
Article in Nephro-urology monthly, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- The effectiveness of Melissa officinalis L. essential oil inhalation on anxiety and symptom burden of hemodialysis patients: a randomized trial study.BMC complementary medicine and therapies · 2025Trial
- The Effectiveness of Spiritual Therapy on Spiritual Well-Being, Self-Esteem and Self-Efficacy in Patients on Hemodialysis.Journal of religion and health · 2020Trial
- Dialysis Symptom Index: Patient-reported outcome measures study of dialysis patients in low resource settings in India.World journal of nephrology · 2025Article
- Article
- Cross-cultural validation of the Portuguese version of the Dialysis Symptom Index for haemodialysis patients.Journal of research in nursing : JRN · 2024Article
- Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis.BMC nephrology · 2021Review
- Negative Religious Coping, Positive Religious Coping, and Quality of Life Among Hemodialysis Patients.Nephro-urology monthly · 2016Article
- The Effect of Continuous Care Model on the Sleep Quality of Hemodialysis Patients.Nephro-urology monthly · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHemodialysis patients have a high physical and psychosocial symptom burden. There is no valid and reliable tool for assessing symptoms of hemodialysis patients in Iran.
objectivesThe aim of this study was to determine psychometric properties of the Persian version of the dialysis symptom index (DSI). PATIENTS AND
methodsThe forward-backward procedure was applied to translate the DSI from English into Persian (Iranian language). The scale (Persian Version) was tested with a convenience sample of 95 patients with end-stage renal disease referred to main hemodialysis centers from December 2012 to June 2013. Validity was assessed using content, face and convergent validity. To test reliability, the kappa values were calculated for test-retest stability and the Cronbach alpha coefficients were also calculated for internal consistency.
resultsThe mean age of patients was 50.4 (SD = 15.72) years and % 61.1 of patients were male. The most commonly reported symptoms were fatigue, being irritable and nervous. Divergent validity was mostly supported by the pattern of association between DSI and SF-36 (r = -0.18- -0.48, P< 0.05). Cronbach's alpha of the DSI was 0.90 and the weighted kappa ranged from 0.21 to 0.93, and it was greater than 0.4 for 25 of the 30 items.
conclusionsThe Iranian version of the DSI had good psychometric properties and can be used to assess symptoms of hemodialysis patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.